Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 42151-42200 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05610618
Study of Brain Activity Underlying Predictive Mechanisms During the Perception of Visual Scenes
NARecruiting
80 participants
Started: Mar 20, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05820672
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
N/ARecruiting
900 participants
Started: Mar 20, 2023 · Completed: Mar 31, 2033
1 condition1 sponsor24 locations
NCT05689502
intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER)
NARecruiting
9 participants
Started: Mar 20, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05760339
Intermittent Fasting Versus Carbohydrate Drinks Before Surgery
NARecruiting
75 participants
Started: Mar 20, 2023 · Completed: Sep 30, 2025
6 conditions2 sponsors1 location
NCT04073797
PET Imaging of Inflammation and Lipid Lowering Study
NARecruiting
63 participants
Started: Mar 20, 2023 · Completed: Mar 1, 2026
4 conditions5 sponsors1 location
NCT05775523
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
N/ARecruiting
500 participants
Started: Mar 20, 2023 · Completed: Mar 31, 2033
1 condition1 sponsor23 locations
NCT06271226
The Effect of Acupressure Applied to Icu on Pain and Physiological Parameters
NARecruiting
30 participants
Started: Mar 20, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05749432
A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors
PHASE1Recruiting
51 participants
Started: Mar 20, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05794451
Developing an Artificial Intelligence System to Detect Cognitive Impairment
N/ARecruiting
4,000 participants
Started: Mar 20, 2023 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT05698810
Preparation and Feasibility of Exams for Expected Studies
NARecruiting
150 participants
Started: Mar 20, 2023 · Completed: Mar 20, 2033
3 conditions2 sponsors1 location
NCT05269615
Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II
PHASE4Recruiting
80 participants
Started: Mar 20, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05700799
HEalth Advocate for Liver Transplant - Pilot
NARecruiting
10 participants
Started: Mar 20, 2023 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT05676255
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
PHASE2Recruiting
452 participants
Started: Mar 20, 2023 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT05769517
PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES
N/ARecruiting
1,300 participants
Started: Mar 20, 2023 · Completed: May 2, 2026
3 conditions1 sponsor1 location
NCT04793152
Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC
NARecruiting
700 participants
Started: Mar 20, 2023 · Completed: Oct 31, 2029
1 condition3 sponsors4 locations
NCT05718778
Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma
NARecruiting
31 participants
Started: Mar 20, 2023 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT05692999
Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study
PHASE3Recruiting
1,166 participants
Started: Mar 20, 2023 · Completed: Jan 31, 2029
1 condition1 sponsor37 locations
NCT06489639
School-based Treatment of Social Anxiety With Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder
NARecruiting
156 participants
Started: Mar 20, 2023 · Completed: Dec 31, 2028
3 conditions4 sponsors1 location
NCT05731141
A Prospective Natural History Study of Lymphatic Anomalies
N/ARecruiting
1,200 participants
Started: Mar 20, 2023 · Completed: Dec 31, 2028
2 conditions1 sponsor2 locations
NCT05174286
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
NARecruiting
880 participants
Started: Mar 19, 2023 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05791760
The Effectiveness of CFT for Reducing Self-criticism in Patients with Complex PTSD: a Single-case Experimental Study
NARecruiting
15 participants
Started: Mar 19, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05794256
Genderspecific Differences in Hormone Levels After Trauma
N/ARecruiting
100 participants
Started: Mar 18, 2023 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT05035771
The IMPACT PAD Study
NARecruiting
20 participants
Started: Mar 18, 2023 · Completed: Oct 6, 2024
1 condition1 sponsor1 location
NCT05724316
Effects of Vitamin D on the Behaviours, Mental, and Physical Health of Prisoners
NARecruiting
110 participants
Started: Mar 18, 2023 · Completed: Mar 31, 2024
5 conditions5 sponsors1 location
NCT05834920
Effects of Neurofeedback and Transcranial Pulse Stimulation on Attention
NARecruiting
180 participants
Started: Mar 17, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05466643
A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus
PHASE3Recruiting
240 participants
Started: Mar 17, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06310915
Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor
N/ARecruiting
30 participants
Started: Mar 17, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05603702
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
PHASE1Recruiting
24 participants
Started: Mar 17, 2023 · Completed: Mar 31, 2026
10 conditions2 sponsors5 locations
NCT05764681
Chronic Postsurgical Pain
N/ARecruiting
500 participants
Started: Mar 17, 2023 · Completed: Jan 31, 2029
2 conditions5 sponsors2 locations
NCT06045923
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
N/ARecruiting
100 participants
Started: Mar 17, 2023 · Completed: Oct 1, 2026
3 conditions1 sponsor1 location
NCT05580419
Impact of 4PCP on Practitioner and Patient Outcomes
NARecruiting
1,188 participants
Started: Mar 17, 2023 · Completed: Oct 31, 2027
1 condition6 sponsors4 locations
NCT05646758
A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
PHASE1Recruiting
140 participants
Started: Mar 17, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor7 locations
NCT05773859
NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer
PHASE1/PHASE2Recruiting
10 participants
Started: Mar 17, 2023 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05743426
Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
N/ARecruiting
180 participants
Started: Mar 17, 2023 · Completed: Jan 1, 2036
2 conditions1 sponsor1 location
NCT05909020
EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem
N/ARecruiting
165 participants
Started: Mar 17, 2023 · Completed: Nov 30, 2023
1 condition2 sponsors4 locations
NCT05757791
Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)
PHASE2Recruiting
16 participants
Started: Mar 17, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05563649
Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa
NARecruiting
200 participants
Started: Mar 17, 2023 · Completed: Oct 1, 2027
1 condition2 sponsors2 locations
NCT05244408
"SCRIBBLE Spinal Cord Injury Blood Biomarker Longitudinal Evaluation"
N/ARecruiting
120 participants
Started: Mar 17, 2023 · Completed: May 30, 2026
4 conditions1 sponsor1 location
NCT05605054
UCSD RELINK: Connecting Adults To Supportive Services
NARecruiting
300 participants
Started: Mar 17, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors2 locations
NCT05758532
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
PHASE4Recruiting
500 participants
Started: Mar 17, 2023 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT05649800
Vascular mEchanisms in, Stroke, dePression, dementiA, and deliRum: The VESPAR Project
N/ARecruiting
140 participants
Started: Mar 17, 2023 · Completed: Aug 26, 2026
5 conditions1 sponsor2 locations
NCT05585905
Virtual Reality in Pediatric Dentistry
NARecruiting
40 participants
Started: Mar 17, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor2 locations
NCT05639400
Thoraflex Hybrid and Relay Extension Post-Approval Study
N/ARecruiting
200 participants
Started: Mar 17, 2023 · Completed: Dec 31, 2036
5 conditions2 sponsors27 locations
NCT05709470
Mind the Heart - Mental Health in Children and Adolescents With Congenital Heart Defects
N/ARecruiting
4,800 participants
Started: Mar 17, 2023 · Completed: Dec 31, 2025
2 conditions5 sponsors1 location
NCT05821010
Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis
PHASE2Recruiting
48 participants
Started: Mar 17, 2023 · Completed: Aug 20, 2026
9 conditions1 sponsor1 location
NCT05487664
RM1 Project 2 - tAN fMRI
NARecruiting
96 participants
Started: Mar 17, 2023 · Completed: Oct 1, 2027
1 condition1 sponsor1 location
NCT06013943
Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC
PHASE2Recruiting
30 participants
Started: Mar 17, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05760378
Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.
PHASE3Recruiting
223 participants
Started: Mar 17, 2023 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT06384378
Systemic and Central Inflammation in AD
PHASE2Recruiting
40 participants
Started: Mar 17, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05634889
The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
NARecruiting
1,350 participants
Started: Mar 17, 2023 · Completed: Dec 31, 2033
1 condition2 sponsors26 locations